Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Tesla
TSLA
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$280M |
| 3 |
Morgan Stanley
MS
|
+$265M |
| 4 |
American Tower
AMT
|
+$262M |
| 5 |
Charles Schwab
SCHW
|
+$261M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$132M |
Sector Composition
| 1 | Technology | 24.26% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.04% |
| 4 | Consumer Discretionary | 12.4% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Fulcrum Therapeutics
FULC
$380M
| $2.43M | ﹤0.01% |
207,670
+59,587
| +40% | +$698K |
|
|
TRVN
2977
DELISTED
Trevena, Inc.
TRVN
| $2.43M | ﹤0.01% |
1,817
+160
| +10% | +$214K |
|
2978
Shore Bancshares
SHBI
$569M
| $2.43M | ﹤0.01% |
166,427
+3,375
| +2% | +$49.3K |
|
2979
Mid Penn Bancorp
MPB
$693M
| $2.42M | ﹤0.01% |
110,690
+6,092
| +6% | +$133K |
|
2980
Laird Superfood
LSF
$62.5M
| $2.41M | ﹤0.01% |
+50,925
| New | +$2.41M |
|
2981
Entravision Communication
EVC
$214M
| $2.4M | ﹤0.01% |
872,031
+55,050
| +7% | +$151K |
|
2982
Canadian Solar
CSIQ
$725M
| $2.39M | ﹤0.01% |
46,684
-851
| -2% | -$43.6K |
|
|
MSON
2983
DELISTED
Misonix Inc
MSON
| $2.39M | ﹤0.01% |
191,192
+3,721
| +2% | +$46.5K |
|
2984
Richmond Mutual Bancorp
RMBI
$142M
| $2.39M | ﹤0.01% |
174,927
-1,280
| -0.7% | -$17.5K |
|
2985
HBT Financial
HBT
$822M
| $2.39M | ﹤0.01% |
157,593
+3,816
| +2% | +$57.8K |
|
2986
Cogent Biosciences
COGT
$1.77B
| $2.38M | ﹤0.01% |
212,354
+187,699
| +761% | +$2.11M |
|
|
PFBI
2987
DELISTED
Premier Financial Bancorp
PFBI
| $2.38M | ﹤0.01% |
179,083
+8,190
| +5% | +$109K |
|
|
CDAK
2988
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $2.37M | ﹤0.01% |
+73,457
| New | +$2.37M |
|
|
TBNK
2989
DELISTED
Territorial Bancorp Inc.
TBNK
| $2.37M | ﹤0.01% |
98,679
+386
| +0.4% | +$9.28K |
|
2990
Fathom Holdings
FTHM
$80.5M
| $2.37M | ﹤0.01% |
65,699
+22,158
| +51% | +$798K |
|
2991
Comscore
SCOR
$31.6M
| $2.36M | ﹤0.01% |
47,513
+3,268
| +7% | +$163K |
|
|
GPX
2992
DELISTED
GP Strategies Corp.
GPX
| $2.36M | ﹤0.01% |
199,169
+3,650
| +2% | +$43.3K |
|
2993
Harrow
HROW
$1.49B
| $2.36M | ﹤0.01% |
344,002
+11,354
| +3% | +$77.9K |
|
2994
Hawthorn Bancshares
HWBK
$221M
| $2.36M | ﹤0.01% |
121,175
+5,444
| +5% | +$106K |
|
|
ARA
2995
DELISTED
American Renal Associates Holdings, Inc
ARA
| $2.35M | ﹤0.01% |
205,402
-2,441
| -1% | -$28K |
|
2996
Atlanta Braves Holdings Series A
BATRA
$2.87B
| $2.35M | ﹤0.01% |
94,537
-3,085
| -3% | -$76.7K |
|
2997
Harvard Bioscience
HBIO
$19.8M
| $2.35M | ﹤0.01% |
546,714
+19,762
| +4% | +$84.8K |
|
2998
Mission Produce
AVO
$838M
| $2.34M | ﹤0.01% |
+155,389
| New | +$2.34M |
|
2999
FVCBankcorp
FVCB
$242M
| $2.34M | ﹤0.01% |
198,789
-547
| -0.3% | -$6.43K |
|
|
PSTX
3000
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.34M | ﹤0.01% |
212,907
+24,067
| +13% | +$264K |
|